Lanean...
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
BACKGROUND: The advent of anti-tumor necrosis factor-α (TNFα) drugs has changed the course of ankylosing spondylitis (AS). While data are available concerning the long term effectiveness of single anti-TNF agents, little has been published about predictors of treatment response in AS. The aim of thi...
Gorde:
| Argitaratua izan da: | BMC Musculoskelet Disord |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4513706/ https://ncbi.nlm.nih.gov/pubmed/26205000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-015-0620-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|